{
    "nctId": "NCT01483001",
    "briefTitle": "Feasibility Study on Stem Cells Sensitivity Assay",
    "officialTitle": "STELLA: a Feasibility Study on Stem Cells Sensitivity Assay",
    "overallStatus": "COMPLETED",
    "conditions": "Lung Cancer, Colorectal Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "N/A",
    "enrollmentCount": 23,
    "primaryOutcomeMeasure": "Feasibility of the project",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically/cytologically confirmed diagnosis of metastatic LC, CRC or BC\n* Availability of tumor tissue suitable for CSCs extraction\n* Performance status of 100% according to Karnofsky score\n* Failure of conventional therapies or no therapy of proven efficacy\n* Adequate hematological, renal and liver functions\n* No concomitant comorbidity potentially interfering with the study\n* Informed consent form signature.\n\nExclusion Criteria:\n\n* Performance status \\<100% according to Karnofsky score\n* Patient suitable for standard therapies\n* Important comorbidity interfering with the study\n* Significant alteration of liver, hematological or renal function(s)\n* No informed consent form signature",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}